利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

104387 条记录 (耗时 0.081 秒)

    Method for converting an organic material into a catalyst for biological hydrosynthesis
    101.
    发明授权
    Method for converting an organic material into a catalyst for biological hydrosynthesis 有权

    公开(公告)号：US12059673B2

    公开(公告)日：2024-08-13

    申请号：US17472854

    申请日：2021-09-13

    申请人： VRM International Pty Ltd

    发明人： Kenneth Michael Bellamy

    IPC分类号： C12P1/00 ,  B01J35/27 ,  B01J37/36 ,  B09B3/60 ,  B09C1/10 ,  C09K17/14

    CPC分类号： B01J37/36 ,  B01J35/27 ,  B09B3/60 ,  B09C1/10 ,  C09K17/14 ,  C12P1/00

    摘要： Method for converting organic material into catalyst for biological hydrosynthesis, comprising providing organic material comprising at least one source of readily available carbon, at least one complex carbon-containing compound and at least one source of protein and contacting the organic material with preparatory catalyst is provided. The organic material is subjected to a size reduction process to produce size-reduced organic material and a solid to liquid ratio of the size-reduced organic material is adjusted to form organic material slurry. The organic material slurry is subjected to a fermentation process to produce amended organic material, by applying a process catalyst to at least a portion of the organic material slurry. A liquid is recovered from the amended organic material and transferred to a fermentation chamber, where it is subjected to a fermentation process to produce amended liquid by applying balancing catalyst to the liquid. The amended liquid is the catalyst.

    Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same
    102.
    发明授权
    Probiotic bacterial strains that produce short chain fatty acids and compositions comprising same 有权

    公开(公告)号：US12059441B2

    公开(公告)日：2024-08-13

    申请号：US16860377

    申请日：2020-04-28

    申请人： International N&H Denmark ApS

    发明人： Michael John Janusz ,  Anna Malgorzata Plechaty

    IPC分类号： A61K35/741 ,  C12N1/20 ,  C12P7/6409

    CPC分类号： A61K35/741 ,  C12N1/20 ,  C12P7/6409

    摘要： Disclosed herein are probiotic bacterial strains or species that produce short chain fatty acids (SCFA), such as butyrate, and compositions comprising the same. The bacterial strains or compositions prepared thereby are used in preparing food, supplements, compositions, and other consumables to provide health benefits, including therapeutic applications, for a variety of disorders, including metabolic, immune, intestinal, and inflammatory disorders. Thus, also disclosed herein are methods of treating a subject suffering from a disorder, such as a metabolic disorder, an immune disorder, an intestinal disorder, or an inflammatory disorder with a composition comprising the probiotic bacterial strains or species disclosed herein. Uses of a bacterial strain or species and a composition comprising them provided in a nutritional product or medicament to improve health or prevent or treat a variety of disorders in a subject are also disclosed.

    METHOD AND SYSTEM FOR PRODUCTION OF ADENOSINE TRIPHOSPHATE
    103.
    发明公开
    METHOD AND SYSTEM FOR PRODUCTION OF ADENOSINE TRIPHOSPHATE 审中-公开

    公开(公告)号：US20240263205A1

    公开(公告)日：2024-08-08

    申请号：US18358637

    申请日：2023-07-25

    申请人： Cornell Research Foundation, Inc.

    发明人： Alexander TRAVIS

    IPC分类号： C12P19/32

    CPC分类号： C12P19/32

    摘要： The present invention relates to a system for production of ATP. This system is comprised of a support and one or more enzymes coupled to that support which are capable of collectively producing ATP from glucose or fructose metabolism. The present invention is additionally directed to a device, which includes the system, and to a method for carrying out a reaction involving the conversion of ATP to ADP using the system.

    POLYPEPTIDES AND USES THEREOF
    107.
    发明公开
    POLYPEPTIDES AND USES THEREOF 审中-公开

    公开(公告)号：US20240262868A1

    公开(公告)日：2024-08-08

    申请号：US18688056

    申请日：2023-02-23

    申请人： SHANXI JINBO BIO-PHARMACEUTICAL CO., LTD.

    发明人： Xia Yang ,  Zhenrui He

    IPC分类号： C07K14/00 ,  A61K8/60 ,  C12N15/63 ,  C12P19/34

    CPC分类号： C07K14/001 ,  A61K8/606 ,  C12N15/63 ,  C12P19/34 ,  C07K2319/20

    摘要： Polypeptides and uses thereof are provided. The polypeptide includes an N-terminal sequence and a C-terminal sequence, wherein the N-terminal sequence includes one or more repeating units including the amino acid sequence shown in SEQ ID NO. 1. The use of a human structural material for tissue filling and augmentation is provided in the present disclosure, which is expected to have a wide range of applications in the fields such as breast augmentation, rhinoplasty and mid-face filling as it does not require transplantation from the human body, yet has the natural advantages of using human tissue for filling.

    Noninvasive diagnosis of fetal aneuploidy by sequencing
    108.
    发明授权
    Noninvasive diagnosis of fetal aneuploidy by sequencing 有权

    公开(公告)号：US12054777B2

    公开(公告)日：2024-08-06

    申请号：US16852663

    申请日：2020-04-20

    申请人： The Board of Trustees of the Leland Stanford Junior University

    发明人： Hei-Mun Christina Fan ,  Stephen R. Quake

    IPC分类号： C12Q1/68 ,  C12P19/34 ,  C12Q1/6869 ,  C12Q1/6883 ,  G01N33/48

    CPC分类号： C12Q1/6883 ,  C12Q1/6869 ,  G01N33/48 ,  C12Q2600/156 ,  G01N2800/387

    摘要： Disclosed is a method to achieve digital quantification of DNA (i.e., counting differences between identical sequences) using direct shotgun sequencing followed by mapping to the chromosome of origin and enumeration of fragments per chromosome. The preferred method uses massively parallel sequencing, which can produce tens of millions of short sequence tags in a single run and enabling a sampling that can be statistically evaluated. By counting the number of sequence tags mapped to a predefined window in each chromosome, the over- or under-representation of any chromosome in maternal plasma DNA contributed by an aneuploid fetus can be detected. This method does not require the differentiation of fetal versus maternal DNA. The median count of autosomal values is used as a normalization constant to account for differences in total number of sequence tags is used for comparison between samples and between chromosomes.